SynthesisClinical and translational science2024

Efficacy, safety, and pharmacokinetics of isoniazid affected by NAT2 polymorphisms in patients with tuberculosis: A systematic review.

Thanakorn Surarak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.